Apyx Medical Financials - Benzinga

Apyx Medical Corp

APYXNASDAQ

Trade with Public

Trade with Public

$3.05

-0.03-0.97%

At close: Aug 31, 5:00 PM EST

$3.12

0.072.3%

After Hours: Aug 28, 6:11 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Apyx Medical Financials

Apyx Medical (APYX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Apyx Medical Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $13.884M Beat $13.175M Estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 22.22 percent increase over losses of $(0.09) per share from the

Benzinga Newsdesk

PRO
Apyx Medical Affirms FY2026 Sales Guidance of $59.000M-$60.000M vs $59.554M Est

Apyx Medical (NASDAQ:APYX) affirms FY2026 sales outlook from $59.000 million-$60.000 million to $59.000 million-$60.000 million vs $59.554 million estimate.

Benzinga Newsdesk

PRO
Apyx Medical Raises FY2026 Sales Guidance from $57.500M-$58.500M to $59.000M-$60.000M vs $57.988M Est

Apyx Medical (NASDAQ:APYX) raises FY2026 sales outlook from $57.500 million-$58.500 million to $59.000 million-$60.000 million vs $57.988 million estimate.

Benzinga Newsdesk

PRO
Apyx Medical Q1 EPS $(0.05) Beats $(0.10) Estimate, Sales $12.490M Beat $10.868M Estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10) by 50 percent. This is a 50 percent increase over losses of $(0.10) per share from the same

Benzinga Newsdesk

Earnings Scheduled For March 10, 2026

Benzinga Insights

Earnings Breakdown: Apyx Medical Q4

Benzinga Insights